SELARL PHARMACIE DE BALDERSHEIM : revenue, balance sheet and financial ratios

SELARL PHARMACIE DE BALDERSHEIM is a French company founded 13 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BALDERSHEIM (68390), this company of category PME shows in 2016 a revenue of 1.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - SELARL PHARMACIE DE BALDERSHEIM (SIREN 752963330)
Kennzahl 2024 2023 2022 2021 2020 2019 2018 2016 2014 2013
Umsatz N/C N/C N/C N/C N/C N/C N/C 1 654 682 € 1 675 893 € 1 771 691 €
Nettoergebnis 9 029 € 20 169 € 150 127 € 93 615 € 79 348 € 78 358 € 57 204 € 33 212 € 72 813 € 43 135 €
EBITDA N/C N/C N/C N/C N/C N/C N/C 115 663 € 170 275 € 132 195 €
Nettomarge N/C N/C N/C N/C N/C N/C N/C 2.0% 4.3% 2.4%

Umsatz und Gewinn- und Verlustrechnung

In 2024, SELARL PHARMACIE DE BALDERSHEIM generates positive net income of 9 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2013-2024: 43 k€ -> 9 k€.

Nettoergebnis (2024) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

9 029 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 109%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 43%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Verschuldungsgrad (2024) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

108.881%

Finanzielle Autonomie (2024) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

42.858%

Anlagenaltersquote (2024) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

17.0%

Entwicklung der Solvenzkennzahlen
SELARL PHARMACIE DE BALDERSHEIM

Positionnement sectoriel

Debt ratio
108.88 2024
2022
2023
2024
Q1: 16.45
Méd: 58.41
Q3: 154.59
Average +5 pts über 3 Jahre

In 2024, the debt ratio of SELARL PHARMACIE DE BALDE... (108.88) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
42.86% 2024
2022
2023
2024
Q1: 28.92%
Méd: 49.95%
Q3: 69.49%
Average

In 2024, the financial autonomy of SELARL PHARMACIE DE BALDE... (42.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 167.97. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2024) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

167.974

Entwicklung der Liquiditätskennzahlen
SELARL PHARMACIE DE BALDERSHEIM

Positionnement sectoriel

Liquidity ratio
167.97 2024
2022
2023
2024
Q1: 129.47
Méd: 182.14
Q3: 260.79
Average +20 pts über 3 Jahre

In 2024, the liquidity ratio of SELARL PHARMACIE DE BALDE... (167.97) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operatives Working Capital (2024) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

0 €

Kundenforderungen (2024) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

0 j

Lieferantenverbindlichkeiten (2024) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

0 j

Lagerumschlag (2024) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Entwicklung des Working Capital und der Zahlungsfristen
SELARL PHARMACIE DE BALDERSHEIM

Positionnement de SELARL PHARMACIE DE BALDERSHEIM dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE DE BALDERSHEIM is estimated at 126 051 € (range 87 780€ - 188 580€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
87k€ 126k€ 188k€
126 051 € Range: 87 780€ - 188 580€
NAF 5 année 2024

Valuation method used

Net Income Multiple
9 029 € × 14.0x = 126 052 €
Range: 87 780€ - 188 580€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DE BALDERSHEIM with other companies in the same sector:

Frequently asked questions about SELARL PHARMACIE DE BALDERSHEIM

What is the revenue of SELARL PHARMACIE DE BALDERSHEIM ?

The revenue of SELARL PHARMACIE DE BALDERSHEIM in 2016 is 1.7 M€.

Is SELARL PHARMACIE DE BALDERSHEIM profitable?

Yes, SELARL PHARMACIE DE BALDERSHEIM generated a net profit of 9 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE DE BALDERSHEIM ?

The headquarters of SELARL PHARMACIE DE BALDERSHEIM is located in BALDERSHEIM (68390), in the department Haut-Rhin.

Where to find the tax return of SELARL PHARMACIE DE BALDERSHEIM ?

The tax return of SELARL PHARMACIE DE BALDERSHEIM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DE BALDERSHEIM operate?

SELARL PHARMACIE DE BALDERSHEIM operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.